DOL Verified Employer

Odin Pharmaceuticals, LLC Salary Data

Government-verified salary data from 39 US Department of Labor filings.

Median Salary
$101,653
39 DOL filings
NJ Approval Rate 76.9% · most recent FY 2025
Median Salary
$101,653
Certified filings
DOL Filings
39
Certified: 30
Unique Job Titles
7
SOC occupations
Approval Rate
76.9%
Certified vs filed

Salary Range

Based on 39 certified filings
DOL-Filed Salary Range
$60,000$76,814$101,653$142,230$175,000
Prevailing Wage Premium - a TruthWage exclusive
+1.8%

Odin Pharmaceuticals, LLC pays close to the DOL minimum wage floor for its filed positions.

The prevailing wage is the minimum salary DOL sets as the floor for this occupation and location. A positive premium means the employer pays above that floor. Source: DOL LCA filings.

Salary Trend

FY2018 - FY2025

Salaries by Job Title

7 occupations with DOL-filed salary data
Job TitleFilingsMedian Salaryvs MarketSalary Range
Chemists 18 $78,707 -6.5%
$72,000$72,000$78,707$108,306$108,306
19-2031.00 8 $76,814 N/A
$60,000$60,000$76,814$85,000$85,000
Natural Sciences Managers 5 $142,230 -11.8%
$142,230$142,230$142,230$170,000$170,000
11-9121.00 5 $166,005 N/A
Insufficient data for salary range.
Managers, All Other 1 N/A N/A
Insufficient data for salary range.
11-9199.01 1 $130,000 N/A
Insufficient data for salary range.
13-1161.00 1 $90,000 N/A
Insufficient data for salary range.

Wage Level Distribution

What does this mean?

Hiring Activity

Full tracker →

Education Requirements

From PERM filings
Job Search

Open Positions at Odin Pharmaceuticals, LLC

Browse current openings and compare them against the government-filed salary data above.

Source: US Department of Labor, Office of Foreign Labor Certification (OFLC) public disclosure files (PERM Form ETA-9089 and LCA Form ETA-9035), and US Bureau of Labor Statistics Occupational Employment and Wage Statistics (OEWS). Salary figures represent employer filings and government survey estimates, not individual worker pay.

Data covers DOL filings from 2018 to 2025.